INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases
JCO Global Oncology · 2024
DOI: 10.1200/go-24-00306 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2024. Verfasst von Swapnil Patel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Upkar Hospital and Cancer Institute, Varanasi, India. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Colorectal Neoplasms, Cytoreduction Surgical Procedures, Hyperthermic Intraperitoneal Chemotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 106 Literaturangaben.
Abstract (Originalsprache)
PURPOSE This manuscript reports the results of the Indian Network for Development of Peritoneal Surface Oncology and Indian Society of Peritoneal Surface Malignancies (INDEPSO-ISPSM) consensus that aimed to provide recommendations for some important aspects management of patients with colorectal peritoneal metastases (CPM) and address some issues unique to India. METHODS The modified Delphi technique was used with two rounds of voting. There were 29 questions on nine main topics—the role of cytoreductive surgery (CRS), patient selection for CRS, preoperative workup, role of systemic chemotherapy (SC), CPM with other visceral metastases, molecular profile, hyperthermic intraperitoneal chemotherapy (HIPEC) and other modalities of intraperitoneal chemotherapy (IPC), prophylactic/preventive strategies, and surveillances after CRS. A consensus was achieved if anyone option received >70 votes (strong consensus >90%). RESULTS Forty-eight surgical (n = 41) and gastrointestinal (n = 7) oncologists were invited; 44 agreed to participate. The response rate was 95.4% (42/44) in round 1 and 93.1% (41/44) in round 2. Overall, a consensus was achieved on 23/29 (79.3%) questions (strong consensus on 6/29 [20.6%]). The panel strongly recommended considering surgery for limited CPM with limited liver metastases (92.5%), not altering the surgical approach in patients with KRAS mutations (91.67%), and limiting the use of IPC for unresectable CPM outside clinical trials (95%). Adjuvant SC was recommended for all patients undergoing CRS (89.47%). CRS is a therapeutic option for selected patients with CPM including those with metachronous CPM (79.49) and signet ring cell cancers (76.92%). HIPEC was recommended outside clinical trials only for patients with peritoneal cancer index 11-15(80%). CONCLUSION The panel recommended CRS for most indications but was very selective in recommending HIPEC and IPC outside clinical trials. These recommendations should be a useful resource in clinical decision making for clinicians treating CPM in India and regions with a similar sociodemographic background.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgical Oncology, Upkar Hospital and Cancer Institute, Varanasi, India.
- Department of Surgical Oncology, Cancer Institute WIA, Adyar, Chennai, India.
- Department of Colorectal Surgery and GI Surgery, Tata Memorial Hospital, Mumbai, India.
- Department of Surgical Oncology, Aster International Institute of Oncology, Bangalore, India.
- Department of GI and HPB Surgery, Rajiv Gandhi Cancer Institute, New Delhi, India.
- Department of Surgical Oncology, Specialty Surgical Oncology, Mumbai, India.
ORCID-Profile: Swapnil Patel, Ramakrishnan Ayloor Sheshadri, Avanish Saklani, Somashekhar Sp, Rohit Kumar, Shivendra Singh, Vivek Sukumar, Aditi Bhatt
Zitieren
APA
Patel, S., Sheshadri, R. A., Saklani, A., Sp, S., Kumar, R., Singh, S., Sukumar, V., & Bhatt, A. (2024). INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases. JCO Global Oncology. https://doi.org/10.1200/go-24-00306
Vancouver
Patel S, Sheshadri RA, Saklani A, Sp S, Kumar R, Singh S, et al. INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases. JCO Global Oncology. 2024. doi:10.1200/go-24-00306
BibTeX
@article{Patel2024,
author = {Patel, Swapnil and Sheshadri, Ramakrishnan Ayloor and Saklani, Avanish and Sp, Somashekhar and Kumar, Rohit and Singh, Shivendra and Sukumar, Vivek and Bhatt, Aditi},
title = {INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases},
journal = {JCO Global Oncology},
year = {2024},
doi = {10.1200/go-24-00306}
}
EUVIMED